Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IPSCthis companyCentury Therapeutics, Inc.	$1.81	-9.04×	0.54×	0.79×	19.64×	85.0%	88.0%	-13.8%	-8.8%	-6.0%	-7.2%	-121.6%	0.27×	-5.3×	0×	5.97×	0.0%	1	-1.94	2	C
CUECue Biopharma, Inc.	$19.03	-1.09×	1.09×	1.05×	-0.24×	-850.1%	100.0%	-96.6%	-96.9%	-100.6%	-86.6%	-75.6%	0.16×	0.93×	-74.29×	2.74×	0.0%	2	-30.14	1	D+
EQEquillium, Inc.	$1.59	-3.97×	4.98×	0×	-5.06×	-77.1%	0.0%	0.0%	0.0%	-78.3%	-83.3%	-16.0%	0.03×	1.33×	0×	10.32×	0.0%	1	14.51	2	C
KPTIKaryopharm Therapeutics Inc.	$0.04	-0.41×	-0.27×	0.55×	-1.69×	-58773.0%	95.9%	-62.1%	-134.2%	66.9%	-236.6%	-93.6%	-0.8×	-1.15×	-1.98×	1.12×	0.0%	2	-27.45	2	B-
OSTXOS Therapies Incorporated	$0.91	-1.43×	-6.72×	0×	-1.43×	-125.9%	0.0%	0.0%	0.0%	471.7%	582.9%	-34767.1%	0×	0.01×	0×	0.03×	0.0%	1	-25.65	2	C
OTLKOutlook Therapeutics, Inc.	$0.45	-0.59×	-0.84×	19.1×	-0.77×	82.8%	46.5%	-4744.3%	-4416.2%	193.9%	-2357.6%	-191.9%	-0.94×	-0.35×	-236.86×	0.38×	0.0%	3	-41.23	2	C
Peer median	—	-1.09×	-0.27×	0.55×	-1.43×	-125.9%	46.5%	-62.1%	-96.9%	66.9%	-86.6%	-93.6%	0×	0.01×	-1.98×	1.12×	0.0%	2	-27.45	2	—